Status:
NOT_YET_RECRUITING
Effect of Standardized Lacrimal Sac Massage Compared With Probing for Congenital Lacrimal Duct Obstruction
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions:
Nasolacrimal Duct Obstruction
Eligibility:
All Genders
3-1 years
Phase:
NA
Brief Summary
Congenital nasolacrimal duct obstruction (CNLDO) is a common ophthalmic condition in children, presenting with tearing and pus overflow, with a prevalence of 5%-20% within 1 year of age. Although most...
Eligibility Criteria
Inclusion
- Age from 3 months to 1 year;
- Presence of at least one symptom of CNLDO (tear spillage, mucous discharge) in one or both eyes;
- No surgical treatment for NLD (probing, balloon dilation, tube placement, DCR, etc.);
- Can cooperate with the examination and subsequent follow-up;
- Guardians agreed to be enrolled in the study and signed an informed consent form.
Exclusion
- Combination of presenting infections of the conjunctiva and cornea;
- Combination of other serious ocular surface and intraocular disorders that may affect the therapeutic effect;
- Congenital malformation syndromes, developmental delays, facial anomalies, facial deformities; history of surgery or injury to the lacrimal duct, history of punctal occlusion, history of lacrimal fistula, history of congenital bulging of the lacrimal sac, history of acute dacryocystitis, history of severe blepharitis, and perinatal abnormalities such as preterm labor, low birth weight, and so on;
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06924723
Start Date
May 1 2025
End Date
January 1 2026
Last Update
April 11 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.